Literature DB >> 12430143

Relationship of serum sex-steroid hormones and prostate volume in African American men.

Michael A Joseph1, John T Wei, Sioban D Harlow, Kathleen A Cooney, Rodney L Dunn, Craig A Jaffe, James E Montie, David Schottenfeld.   

Abstract

BACKGROUND: Previous epidemiologic investigations of the associations of sex-steroid hormones and benign prostatic hyperplasia (BPH) have focused on predominately white populations. The objective of this study was to evaluate potential associations of body mass index (BMI), cigarette smoking, use of alcohol, and endogenous sex-steroid hormones with prostate volume in a population-based sample of African American (AA) men, ages 40-79 yr.
METHODS: A total of 369 AA men without clinical evidence of prostate cancer were identified in the Flint Men's Health Study by using a population-based sampling procedure. All subjects underwent a complete urologic evaluation that included prostate volume determination by transrectal ultrasonography and serum assays for androgens and estrogens.
RESULTS: After age adjustment, BMI (weight (kg)/height (m)2) was positively correlated with increasing levels of androstanediol glucuronide (AG), estradiol (E2), estrone sulfate (E1S), and the ratios of E2:total testosterone (TT) and E2:free testosterone (FT); however, increasing BMI was negatively correlated with androstenedione (AD), FT, TT, and sex hormone-binding globulin (SHBG). Multivariable regression models demonstrated that prostate volume increased with age (P < 0.001) and BMI (P = 0.02) and decreased with increasing levels of SHBG (P = 0.01). Larger prostatic volumes were also marginally associated with increasing levels of TT (P = 0.058).
CONCLUSION: Circulating serum levels of SHBG and endogenous sex-steroid hormones are correlated with prostate volume and potentially impact the natural history of BPH. However, longitudinal studies are needed to demonstrate the temporal relationships of hormones and growth factors in the pathogenesis of BPH in AA men. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12430143     DOI: 10.1002/pros.10154

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  14 in total

Review 1.  Andropause: is the emperor wearing any clothes?

Authors:  S H Tariq; M T Haren; M J Kim; J E Morley
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 2.  Risk factors for benign prostatic hyperplasia.

Authors:  Steven J Jacobsen
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

3.  Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.

Authors:  Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; George G Klee; Michael M Lieber; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2011-03-02       Impact factor: 4.897

Review 4.  MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans.

Authors:  J Jones; W Grizzle; H Wang; C Yates
Journal:  Biotech Histochem       Date:  2013-08-01       Impact factor: 1.718

5.  Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study.

Authors:  Peng Zhang; Wan-Li Hu; Bei Cheng; Yang-Jun Zeng; Xing-Huan Wang; Tong-Zu Liu; Wei-Bing Zhang
Journal:  Int Urol Nephrol       Date:  2015-12-19       Impact factor: 2.370

6.  Metabolic factors associated with benign prostatic hyperplasia.

Authors:  J Kellogg Parsons; H Ballentine Carter; Alan W Partin; B Gwen Windham; E Jeffrey Metter; Luigi Ferrucci; Patricia Landis; Elizabeth A Platz
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958

7.  Estimation of prostate size in community-dwelling men.

Authors:  Debra J Jacobson; Jennifer L St Sauver; Alexander S Parker; Michaela E McGree; Aruna V Sarma; Cynthia J Girman; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2010-08-30       Impact factor: 2.649

8.  Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.

Authors:  Qin-Song Zeng; Chuan-Liang Xu; Zhi-Yong Liu; Hui-Qing Wang; Bo Yang; Wei-Dong Xu; Tai-Le Jin; Cheng-Yao Wu; Gang Huang; Zheng Li; Bo Wang; Ying-Hao Sun
Journal:  Asian J Androl       Date:  2012-07-02       Impact factor: 3.285

9.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Jeannette M Schenk; YoonJu Song; Kathryn B Arnold; Marian L Neuhouser; Phyllis J Goodman; Daniel W Lin; Frank Z Stanczyk; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2008-10-21       Impact factor: 4.897

10.  Relationship between serum total testosterone and prostate volume in aging men.

Authors:  Bo-Wen Xia; Si-Cong Zhao; Zong-Ping Chen; Chao Chen; Tian-Shu Liu; Fan Yang; Yong Yan
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.